Fractional CFO Advisory for Maryland Cannabis Operators: Capital Optimization

Cannabis capital is expensive because the lender pool is small, the collateral is unusual, and federal illegality has historically excluded conventional bank credit. That reality makes capital structure a first-order determinant of enterprise value in a way it is not for most middle-market businesses. Our restructuring work starts with a complete inventory of existing obligations: principal, rate, amortization, covenants, security interests, personal guarantees, conversion features, and the practical behavior of each lender under stress.

From that base we build a capital stack model showing the blended cost of capital, the debt service coverage under a base case and two downside cases, and the point at which each covenant breaks. Operators are frequently surprised by the result, because high-rate short-amortization cannabis debt consumes cash at a pace that a profit-and-loss statement does not reveal. Profitable operators fail on amortization schedules far more often than on margins.

Restructuring options we evaluate include: refinancing into longer amortization even at a comparable rate, since duration often matters more than price; sale-leaseback of owned real property to convert an illiquid asset into working capital, priced carefully because the lease obligation is permanent; equipment financing on production assets to free general working capital; converting a portion of debt to equity or to a revenue-participation instrument where the lender relationship supports it; and consolidating multiple facilities to eliminate overlapping covenants and cross-default risk.

Every option is modeled against the same measures: monthly cash service, covenant headroom, dilution, control implications, and the effect on the enterprise's attractiveness to a future acquirer. A structure that reduces this quarter's payment while installing a lien that blocks a future transaction is not an improvement. We present the tradeoffs explicitly and let owners decide with the numbers in front of them.

Underneath all of it sits the thirteen-week cash forecast, maintained weekly and reconciled to actuals. It covers payroll, tax remittances including 280E-inflated estimates, debt service, license renewals, inventory purchasing, and capital commitments. It is the single most useful document a cannabis operator can maintain, and it is the first thing a serious lender asks to see.

Inventory is usually the largest asset on a Maryland cannabis balance sheet and the least well understood. Valuation strategy affects taxable income through cost of goods sold, affects borrowing base calculations where inventory is collateral, and affects reported margin, which is what investors price. It deserves deliberate policy rather than default settings inherited from an accounting package.

We set the costing method explicitly and apply it consistently: specific identification where batch tracking supports it, weighted average where product is fungible, and a documented approach to freight, packaging, testing, and conversion cost inclusion. We define the treatment of yield loss, normal spoilage, quality-control holds, samples, and destruction, and we separate abnormal losses so that unit costs remain meaningful. We establish a reserve policy for aging, damaged, and slow-moving inventory with objective triggers rather than judgment applied at year end.

Working capital management follows from that. We measure inventory turns by category, days of supply against demand, and the carrying cost of holding product that will be discounted before it sells. In cultivation, the analysis extends to whether the production plan matches the sales plan; overproduction in a maturing Maryland market converts cash into inventory that sells at a discount, and that conversion is often invisible on an income statement until the write-down arrives.

For financed operators the borrowing base is recalculated with the lender's eligibility rules applied, so that the operator knows availability before drawing rather than after a rejection. Where the lender's rules exclude categories the operator holds heavily, that is a structural finding worth addressing in the next financing conversation.

Joint venture financing is common in Maryland because license holders and capital holders are frequently different parties, and ownership rules constrain how they combine. We model each proposed arrangement on economics rather than labels: what each party contributes, what each receives under a range of performance outcomes, how losses are shared, what happens on default or deadlock, and how the arrangement is characterized for tax. A management agreement, a services agreement, a profit-participation loan, and an equity stake can produce similar economics with materially different tax and regulatory consequences.

Every structure is tested against the Maryland Cannabis Administration's ownership and control framework before it is documented, because an arrangement that confers effective control without disclosure creates a licensing problem that dwarfs any tax benefit. We coordinate with counsel so that the financial model and the regulatory filing describe the same transaction.

For multi-state operators, transfer pricing between affiliated entities is a recurring exposure. Intercompany charges for management services, intellectual property licensing, shared services, real property leasing, and product transfers must be priced at arm's length and supported by documentation. In a 280E environment the stakes are elevated: shifting cost into a plant-touching entity where it is non-deductible, or shifting margin into a jurisdiction with a different regime, attracts attention from both federal and state examiners. We prepare intercompany agreements, a defensible pricing methodology, benchmarking support where available, and an allocation schedule applied consistently, then review it annually as the operating footprint changes.

Investor and lender reporting is standardized so that comparability across periods is preserved. The recurring package includes a balance sheet, income statement with location and department detail, cash flow statement, thirteen-week forecast, covenant compliance certificate, EBITDA bridge with each adjustment itemized, inventory roll-forward, and a written management discussion covering variances, risks, and actions taken. Capital providers fund operators they can predict; the reporting is how prediction becomes possible.

Where a capital raise or a transaction is contemplated, we prepare the data room in parallel with ordinary reporting: historical financials, tax filings, the cost accounting methodology, Metrc reconciliations, license documentation, material contracts, and a quality-of-earnings-ready adjustment schedule. Operators who maintain this continuously close transactions faster and at better terms than operators who assemble it under a signed letter of intent.

A part-time CFO engagement is scoped to the license type, because the financial questions differ. Dispensaries need basket economics, labor scheduling against traffic, discount and promotion margin impact, and location-level profitability where more than one storefront is open. Cultivators need cost per gram by room and cycle, yield variance, energy load against output, and a production plan that matches the sales plan rather than converting cash into unsold inventory. Processors and manufacturers need conversion cost per batch, throughput and downtime analysis, packaging and input pricing, and contract profitability by customer. Vertically integrated operators need all of it plus honest internal transfer pricing, so that a weak segment is not hidden inside a strong one.

Across every operator type the recurring work is the same set of disciplines: cash flow management and thirteen-week forecasting, annual budgeting with monthly phasing, margin and product profitability analysis, management reporting that a non-financial operator can act on, financial controls over cash and inventory, and strategic financial planning ahead of expansion, financing, or a sale. Much of this is cannabis consulting in the financial and accounting sense — we advise on money, systems, and reporting, and we coordinate with your attorney on licensing and legal questions rather than answering them ourselves.

Scope and cadence are set at the outset — typically a fixed monthly engagement sized to the number of licenses, locations, and entities involved, with defined deliverables. We quote it after a consultation, once we have seen the actual footprint and the state of the records.